茯苓治疗栓塞后综合征机制的网络药理学分析OA
Network pharmacology analysis of the mechanism underlying the treatment of post-embolization syndrome with Fuling(Poria)
目的 探讨茯苓治疗栓塞后综合征(PES)的活性成分、主要靶点及信号通路.方法 通过TCMSP和HERB数据库预测茯苓活性成分及其作用靶点,通过OMIM和GeneCards数据库预测PES靶点,将两者取交集得到茯苓和PES的共同靶点.通过STRING数据库进行共同靶点的蛋白互作分析,根据中位值法筛选核心靶点.通过Metascape数据库进行共同靶点的基因本体(GO)及京都基因与基因组百科全书(KEGG)富集分析,预测相关功能和信号通路.通过CB-Dock2 平台进行活性成分和核心靶点的分子对接,预测结合位点和结合能.结果 从茯苓中筛选出 6 个活性成分,分别为stellasterol、ergosterol peroxide、trame-tenolic acid、16alpha-hydroxydehydrotrametenolic acid、cerevisterol及hederagenin.同时,获得茯苓与PES的共同靶点 26 个,并从中筛选出TNF、IL1B、IL6、PTGS2、CASP3、BCL2 等 6 个核心靶点.富集分析显示,生物过程(BP)主要涉及对脂多糖的免疫应答、炎症反应调节,细胞组分(CC)主要涉及膜筏和小窝,分子功能(MF)主要涉及转录因子结合和细胞因子活性;主要信号通路包括IL-17、TNF和AGE-RAGE通路及细胞凋亡.分子对接结果显示,活性成分与核心靶点的结合活性良好.结论 茯苓活性成分可能通过TNF、IL1B、IL6、PTGS2、CASP3、BCL2 等核心靶点,调控IL-17、TNF和AGE-RAGE信号通路及细胞凋亡,进而治疗PES.
Objective To investigate the active constituents,major targets,and signaling pathways through which Fuling(Poria)treats post-embolization syndrome(PES).Methods The active constituents and their corresponding targets of Fuling(Poria)were predicted using the TCMSP and HERB databases,whereas targets associated with PES were predicted using the OMIM and GeneCards databases.The two target sets were intersected to identify the common targets shared by Fuling(Poria)and PES.Protein-protein interaction analysis of the common targets was performed using the STRING database,and core targets were screened using the median-based method.Gene ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses of common targets were conducted using the Metascape database to predict the associated biological functions and signaling pathways.Molecular docking between active constituents and core targets was performed using the CB-Dock2 platform to predict binding sites and binding energies.Results Six active constituents of Fuling(Poria)were screened,including stellasterol,ergosterol peroxide,trametenolic acid,16alpha-hydroxydehydrotrametenolic acid,cerevisterol,and hederagenin.A total of 26 common targets shared by Fuling(Poria)and PES were obtained,from which six core targets(TNF,IL1B,IL6,PTGS2,CASP3,BCL2)were identified.GO enrichment results indicated that the biological processes(BP)mainly involved the immune response to lipopolysaccharide and regulation of inflammatory responses;the cellular components(CC)mainly involved membrane rafts and caveolae;and the molecular functions(MF)mainly involved transcription factor binding and cytokine activity.The major signaling pathways included the IL-17,TNF,and AGE-RAGE signaling pathways and apoptosis.Molecular docking showed that the active constituents exhibited favorable binding affinities for the core targets.Conclusion The active constituents of Fuling(Poria)may act on core targets including TNF,IL1B,IL6,PTGS2,CASP3,and BCL2 to regulate the IL-17,TNF,and AGE-RAGE signaling pathways and apoptosis,thereby exerting therapeutic effects on PES.
童金金;刘羽;文婷;刘瑜;张月娟
湖南中医药大学,湖南 长沙 410208||湖南中医药大学第一附属医院,湖南 长沙 410007湖南中医药大学第一附属医院,湖南 长沙 410007湖南中医药大学第一附属医院,湖南 长沙 410007湖南中医药大学第一附属医院,湖南 长沙 410007湖南中医药大学,湖南 长沙 410208||湖南中医药大学第一附属医院,湖南 长沙 410007
医药卫生
茯苓肝动脉灌注化疗栓塞术栓塞后综合征网络药理学分子对接
Fuling(Poria)transcatheter arterial chemo-embolizationpost embolization syndromenetwork pharmacologymolecular docking
《药食同源杂志》 2026 (8)
676-685,10
湖南省教育厅重点项目(22A0247).
评论